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Comparison of oxidative stress status between subjects with or without warts is absent in the literature. In this study, we evaluated
31 consecutive patients with warts (15 female, 16 male) and 36 control cases with no evidence of disease to determine the eﬀects
of oxidative stress in patients with warts. The patients were classiﬁed according to the wart type, duration, number, and location
of lesions. We measured the indicators of oxidative stress such as catalase (CAT), glucose-6-phosphate dehydrogenase (G6PD),
superoxide dismutase (SOD), and malondialdehyde (MDA) in the venous blood by spectrophotometry. There was a statistically
signiﬁcant increase in levels of CAT, G6PD, SOD activities and MDA in the patients with warts compared to the control group (P<
.05). However, we could not deﬁne a statistically signiﬁcant correlation between these increased enzyme activities and MDA levels
and the type, the duration, the number, and the location of lesions. We determined possible suppression of T cells during oxidative
stressthatmighthaveanegativeeﬀectontheprognosisofthedisease.Therefore,weproposeanargumentfortheappropriatenessto
give priority to immunomodulatory treatment alternatives instead of destructive methods in patients with demonstrated oxidative
stress.
INTRODUCTION
Warts is a common infectious disease caused by hu-
man papilloma virus (HPV), aﬀecting the skin and mu-
cosa [1, 2]. Skin, the biggest organ of the body, constitutes
a signiﬁcant barrier against the infectious agents and pro-
duces many inﬂammatory mediators and other immune
response factors [2]. Besides, a T-cell defect is suggested
to lead to disease in cases infected with HPV [3]. In the
treatment of the disease, drugs such as levamisole [4, 5],
cimetidine [6, 7], zinc [8], and topical imiquimod [9, 10],
which have immunomodulatory eﬀects, were also used
and diﬀerent success levels were reported.
Oxidative stress appears as a result of destroyed bal-
ancebetweenoxidantsandantioxidantsinthebody.Cata-
lase (CAT), superoxide dismutase (SOD), and glucose-6-
phosphate dehydrogenase (G6PD) are the most impor-
tantantioxidantenzymesinthecells[11].SODisapotent
protective enzyme that can selectively scavenge the super-
oxide radicals by catalyzing their dismutation to hydro-
gen peroxide. The other antioxidative enzyme CAT con-
vertshydrogenperoxidetowater.G6PDcatalyzesthecon-
version reaction of glucose to glucose-6-phosphate pro-
ducing one of the main reducing equivalents of the cell
NADPH. Malondialdehyde (MDA) is the end product of
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lipid peroxidation and is accepted as the speciﬁc indica-
tor of the oxidative stress [12]. Therefore, assessment of
MDA is probably the most commonly applied method for
the measurement of lipid peroxidation. Antioxidant en-
zymes in the cell reduce the oxidant activity and prevent
the eﬀects of oxidative stress [11]. It has been claimed that
the balance of oxidants and antioxidants may play an im-
portant role in the spontaneous regression of HPV infec-
tions [13]. It is also thought that antioxidant systems have
a connection with immunity [14].
In this study, the oxidative stress in a group of patients
with nongenital warts was investigated.
MATERIALS AND METHODS
We evaluated 31 consecutive patients admitted to our
dermatology clinic with untreated nongenital warts with
verrucaplantaris,verrucaplanus,andverrucavulgaris(15
female, 16 male) and 36 control cases with no evidence
of disease. Patients with history of genital and ﬁliformis
warts, systemic or other cutaneous diseases, smoking, and
vitaminsorantiinﬂammatorymedicationswereexcluded.
The patients were stratiﬁed according to duration of dis-
ease (≤ 1y e a rv e r s u s> 1 year), and the number of lesions
(≤ 10 and > 10 lesions). The locations of the lesions were
recorded as face, upper extremity, and lower extremity. A
signed informed consent was taken from each subject.
Blood from forearm vein was collected into 5 mL Va-
cutainer tubes containing potassium EDTA. The blood
samples were centrifuged at 1000xg for 10minutes at 4◦C234 Sezai Sasmaz et al 2005:4 (2005)
Table 1.Themeanvaluesofcatalase(CAT),glucose-6-phosphatedehydrogenase(G6PD),andsuperoxidedismutase(SOD)activities
and malondialdehyde (MDA) levels in patients and control groups (mean ± standard deviation).
Subjects/statisical value CAT (U/g Hb) G6PD (U/g Hb) SOD (U/g Hb) MDA (nmol/mL)
Patients (n = 31) 17.7 ±5.21 2 .4 ±3.2 3127 ±1176 3.9 ±0.5
Control group (n = 36) 15.4 ±2.09 .6 ±1.8 2178 ±484 2.1 ±0.2
P (t test) .02 <. 001 <. 001 <. 001
to remove plasma. The buﬀy coat on the erythrocyte sed-
iment was separated carefully after the plasma was re-
moved. The erythrocytes were washed three times with
0.9% NaCl solution to remove the plasma remnant. Af-
ter each procedure, erythrocyte saline mixture was cen-
trifugedat1000xgfor10minutesat4◦C.Thehemolysates
were prepared from the washed cells to measure the pa-
rameters of biochemical workup.
CAT activities were determined by measuring the de-
crease in hydrogen peroxide concentration at 230nm
by the method of Beutler [15]. Assay medium con-
sisted of 1M Tris-HCl, 5mM Na2EDTA buﬀer solu-
tion (pH 8.0), 1M phosphate buﬀer solution (pH 7.0),
and 10mM H2O2. CAT activity was expressed as U/g
hemoglobin.
SOD activity was measured according to the method
described by Fridovich [16]. This method employs
xanthine and xanthine oxidase to generate superoxide
radicals, which react with p-iodonitrotetrazolium vi-
olet (INT) to form a red formazan dye, which was
measured at 505nm. Assay medium consisted of the
0.01M phosphate buﬀer, CAPS (3-cyclohexylamino-1-
propanesulfonic acid) buﬀer solution (50mM CAPS,
0.94mM EDTA, saturated NaOH) with pH of 10.2, so-
lution of substrate (0.05mM xanthine, 0.025mM INT),
and 80U/L xanthine oxidase. SOD activity was expressed
as U/g hemoglobin.
G6PD activity was determined at 37◦C according to
Beutler [15]. The reaction mixture contained 1M Tris-
HCl of pH 8.0, 6mM G6P, Na salt, 2mM NADP, 0.1M
MgCl2, and hemolysate in total volume of 3mL. One unit
of enzyme activity is the amount that catalyzed the reduc-
tion of 1mM of NADP per minute.
Lipid peroxidation level in the plasma samples was
expressed in MDA. It was measured according to pro-
cedure of Ohkawa et al [17]. The reaction mixture con-
tained 0.1mL sample, 0.2mL of 8.1% sodium dodecyl
sulfate (SDS), 1.5mL of 20% acetic acid, and 1.5mL of
0.8% aqueous solution of thiobarbituric acid (TBA). The
mixture pH was adjusted to 3.5 and volume was ﬁnally
made up to 4.0mL with distilled water and 5.0mL of the
mixture of n-butanol and pyridine (15:1, v/v) was added.
The mixture was shaken vigorously. After centrifugation
at 4000rpm for 10minutes, the absorbance of the organic
layer was measured at 532nm.
The hemoglobin level was measured with a spec-
tronic-UV120 spectrophotometer by the method of
cyanomethemoglobin.
StatisticalassessmentswerecarriedoutwithSPSS10.0
package program. Chi-square was used for the compari-
son of frequency, t test for the comparison of averages,
andSpearmancorrelationtestfortheassessmentofcorre-
lation. For age-related analysis, both groups were divided
into pediatric (aged up to 15 years) and adult (ages of 16–
55 years) subgroups and evaluated with Mann-Whitney
U test. Statistical diﬀerence was taken as P<. 05.
RESULTS
Age and sex distributions of patient and control
groups were determined as similar. The patients were be-
t w e e n5a n d5 5( m e a n :2 1± 13) years old and the mem-
bers of the control group were between 5 and 50 (mean:
20±13)yearsold.Lesionswerelocatedonthefaceof7pa-
tients,upperextremityof11patients,andlowerextremity
of13patients.Thetypeofdiseasewasverrucaplanusin10
patients, verruca vulgaris in 8 patients, and verruca plan-
taris in 13 patients. The number of lesions was 10 and less
in 19 patients, while it was more than 10 in 12 patients.
The duration of the disease was shorter than 12 months
in 26 patients, whereas it was longer in 5 patients.
Average values of the levels of antioxidant enzymes
and MDA belonging to patient and control groups are
summarized in Table 1. According to this, CAT, G6PD,
SOD, and MDA levels in the patient group were found to
bestatisticallyhigh.However,wecouldnotdeﬁneastatis-
tically signiﬁcant correlation between these increased en-
zymeactivitiesandMDAlevelsandthetype,theduration,
the number, and the location of lesions.
In both patient and control groups, CAT, G6PD, SOD,
and MDA parameters of pediatric age subgroup were not
found diﬀerent versus adult age subgroup (P<. 05). Ac-
tivities of CAT in pediatric patients and G6PD in adult
patients were found indiﬀerent compared to the same-age
controlgroupsubjects.However,theotheroxidativestress
parameters were found to be higher than the same-age
c o n t r o ls u b j e c t s( T a b l e s2 and 3).
DISCUSSION
In this prospective clinical study, we have chosen ery-
throcyte as a representative cell of the body to estimate
the antioxidant enzyme activities in patients with non-
genital warts because these enzymes are constitutively ex-
pressed in several cell lines including immature erythro-
cytes. On the other hand, erythrocytes are easy to obtain.2005:4 (2005) Oxidative Stress in Warts 235
Table 2.Themeanvaluesofcatalase(CAT),glucose-6-phosphatedehydrogenase(G6PD),andsuperoxidedismutase(SOD)activities
and malondialdehyde (MDA) levels in pediatric subgroups in both groups (mean ± standard deviation).
Subjects/statisical value CAT (U/g Hb) G6PD (U/g Hb) SOD (U/g Hb) MDA (nmol/mL)
Patients (n = 12) 15.2 ±4.41 3 .3 ±2.6 3219 ±1098 3.9 ±0.4
Control group (n = 18) 15.5 ±2.19 .2 ±1.9 2112 ±427 2.1 ±0.1
P (Mann-Whitney U) .68 .001 .003 <. 001
Table 3.Themeanvaluesofcatalase(CAT),glucose-6-phosphatedehydrogenase(G6PD),andsuperoxidedismutase(SOD)activities
and malondialdehyde (MDA) levels in adult subgroups in both groups (mean ± standard deviation).
Subjects/statisical value CAT (U/g Hb) G6PD (U/g Hb) SOD (U/g Hb) MDA (nmol/mL)
Patients (n = 19) 19.3 ±5.11 1 .8 ±3.2 3068 ±1247 3.8 ±0.5
Control group (n = 18) 15.3 ±1.81 0 .1 ±1.7 2242 ±539 2.1 ±0.3
P (Mann-Whitney U) .01 .13 .04 <. 001
The increased antioxidant enzyme activities of erythro-
cyteinthepatientscomparedtohealthycontrolsmightbe
a peripheral response of the organism to increased oxida-
tivestress.Itcanbeputforwardthatincreasedantioxidant
enzymeactivitiesmayreﬂectaprecedingcellularoxidative
stress or serve as a compensatory mechanism. Overpro-
ductionofbothsuperoxideradicalsandH2O2 mayinduce
the expression of SOD and CAT enzymes. Since H2O2 is a
neutral and highly liposoluble compound that can easily
passthroughthecytoplasmicandsubcellularmembranes,
an excess amount of H2O2 found in or out of the cell
membrane can pass through the erythrocyte membrane
into the cytosol and thus cause an increase in the activi-
ties of CAT. In age-related analysis of our study, while the
other antioxidant parameters were found to be increased
in children with warts and CAT was not increased, this
situation might be accounted for by the high value of in-
tracellular superoxide anion radical in children.
The elevated MDA levels in patient group suggested
the increased lipid peroxidation and thus oxidative stress
still existed despite increased activities of the antioxidant
enzymes. The lack of signiﬁcant rise in the activity of
G6PDinadultpatientswithwartsdespitetheriseofother
antioxidant parameters in the age-related analysis of this
study might originate from the improved detoxiﬁcation
capacity in that age group.
HPVs are unenveloped double-stranded DNA viruses
[18] and they infect human with the direct contact of in-
fected materials to the epidermis [1]. They cause persis-
tent infections [15] leading to malignant or benign neo-
plastic lesions on infected cutaneous and mucosal epithe-
lium [19]. HPV resembles nonlytic viruses and does not
cause death of the cell but leads to desquamation in the
aﬀected cells [20]. In a controlled molecular study, it was
shown that the spontaneous regression of the disease may
be related with cellular immunity, mainly CD4+ Tl y m -
phocytes and macrophages [21]. After AIDS and renal
transplantation, observing many warts infections resis-
tant to treatment in the immunosuppressed patients may
lead us to think that a T-cell defect, which may create ten-
dency to the disease, may constitute the basis for the dis-
ease [3]. Immunomodulatory eﬀect of some drugs tak-
ing place among the treatment alternatives is also known
[4,5,6,7,8,9,10].Forexample,imiquimod,oneofthem,
increases the interleukin-1, -6, and -8 and tumor necrosis
factor-α and shows antiviral eﬀects [9].
Reactiveoxygenspecies(ROS)aretoxicmoleculesand
have important roles in many inﬂammatory skin diseases
[14]. According to a view under dispute, T lymphocytes
also produce ROS when faced with a stimulus. In some
studies, it was put forward that antioxidant system stim-
ulated T cells; on the other hand, in some other studies
an opposite result was obtained and it was disclosed that
oxidative stress suppressed T-cell activation [22].
It is known that all the viral proteins of HPV are
potentially immunogenic. Besides, it reminds us of the
thought that long-lasting warts’ local immunosuppres-
sion or viral proteins could not be recognized. In addi-
tion to the low expression of early HPV proteins on basal
epithelium, it may be thought that weak local release of
cytokine may prevent the exact eradication of the dis-
ease [2]. The results we found lead us to think that when
antioxidant system, which has close connection with im-
mune system, overworks with exogenous stimulus, it sup-
presses T cells or slows them down. If increased antiox-
idant activity also activates cellular immunity, we would
expecttoseeafasterregressioninthediseaseandlesserre-
lapse. Therefore, we propose an argument for the appro-
priateness to give priority to immunomodulatory treat-
ment alternatives instead of destructive methods in pa-
tients with demonstrated oxidative stress. Moreover, as
the views concerning the relation between T lymphocytes
and oxidative stress are under dispute, new studies, which
will clarify it, should be supported.236 Sezai Sasmaz et al 2005:4 (2005)
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